AAN 2026
18 - 22 April 2026
Semaglutide Impacts Proteomic Signatures Related to Dementia Risk in the SELECT Cardiovascular Outcomes Trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.